Alembic Pharmaceuticals’ wholly owned subsidiary, Orit Laboratories LLC has received US Food & Drug Administration (USFDA) approval for Glycopyrrolate tablets USP, 1 mg and 2 mg.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.